-
公开(公告)号:EP4408540A1
公开(公告)日:2024-08-07
申请号:EP22877405.5
申请日:2022-09-30
申请人: Coty Inc. , Joyal, David
发明人: JOYAL, David
CPC分类号: A61Q1/10 , A61K8/64 , A61K8/34 , A61K2800/7820130101
-
公开(公告)号:EP3160438B9
公开(公告)日:2024-07-17
申请号:EP15738543.6
申请日:2015-06-30
IPC分类号: A61K9/00 , A61K9/08 , A61Q7/00 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/18 , A61K8/49 , A61K8/34 , A61K8/37 , A61K8/67 , A61K8/02 , A61K8/04 , A61K8/14 , A61K8/06 , A61K31/505 , A61K31/506 , A61P17/14
CPC分类号: A61K8/34 , A61K8/676 , A61K9/0014 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/186 , A61K9/08 , A61K8/0291 , A61K8/044 , A61K8/062 , A61K2800/4920130101 , A61K31/506 , A61K8/4953 , A61K8/37 , A61Q7/00 , A61K8/14 , A61P17/14
-
-
公开(公告)号:EP4344696A1
公开(公告)日:2024-04-03
申请号:EP22833670.7
申请日:2022-06-30
申请人: D-Nature Co., Ltd.
发明人: KIM, Byoungha , YUN, Sangkyu
IPC分类号: A61K8/49 , A61Q7/00 , A61K31/343 , A61P17/14
摘要: Disclosed is a composition for preventing autoimmune disease or for preventing and treating hair loss. A functional composition for hair loss according to an embodiment of the present invention is a composition for preventing and treating autoimmune disease or hair loss, the functional composition comprising a functional ingredient for hair loss extracted from a natural substance, wherein the functional ingredient for hair loss comprises, as an active ingredient, any one or more selected from the group consisting of Brevilin A, Arnicolide D, Arnicolide C, and Microhelenin C.
-
5.
公开(公告)号:EP4344556A1
公开(公告)日:2024-04-03
申请号:EP22833682.2
申请日:2022-06-30
申请人: Cosmax Bio Co., Ltd.
发明人: SHIN, Yu Kyong , KIM, Hyoun Jea , AHN, Hye Shin , NA, Chang Seon
IPC分类号: A23L33/10 , A23L33/105 , A23P10/20 , A61K8/49 , A61K8/9789 , A61Q5/00 , A61Q7/00 , A61K31/353 , A61P17/14
摘要: Provided is a composition for improving a hair or scalp condition including hydrangenol as an active ingredient. The composition including hydrangenol as an active ingredient inhibits the activity of 5α-reductase, which is a hair loss mediating factor, promotes growth of dermal papilla cells, alleviates roughness of hair cuticles, and increases the tensile strength of hair. Accordingly, the composition can be effectively used to improve the condition of hair or scalp.
-
公开(公告)号:EP4294533A1
公开(公告)日:2023-12-27
申请号:EP22756771.6
申请日:2022-02-15
-
-
公开(公告)号:EP4238570A1
公开(公告)日:2023-09-06
申请号:EP22865878.7
申请日:2022-12-19
发明人: GAO, Hongwei , YUAN, Renyikun , YANG, Shilin
IPC分类号: A61K31/704 , A61P17/14 , A61K8/63 , A61Q7/00
摘要: The present disclosure relates to a composition capable of promoting hair growth, comprising a pulchinenoside active component of pulchinenoside B4 or pulchinenoside B5. The experiment results are showed that the composition of the present disclosure can promote hair growth in a hair removal area of mice, improve its growth speed and increase the number of hair follicles, and has non-toxic side effects, low cost and rapid curative effect. The present disclosure also discloses a drug capable of promoting hair growth, comprising a pulchinenoside active component of pulchinenoside B4 or pulchinenoside B5. The present disclosure also discloses pulchinenoside B4 or pulchinenoside B5 as an active component in preparation of the composition or drug capable of promoting hair growth
-
公开(公告)号:EP4221677A1
公开(公告)日:2023-08-09
申请号:EP21786474.3
申请日:2021-10-01
-
公开(公告)号:EP4205756A1
公开(公告)日:2023-07-05
申请号:EP21862142.3
申请日:2021-08-30
IPC分类号: A61K36/634 , A61P13/08 , A61P17/14 , A61K8/9789 , A61Q7/00
摘要: The present invention relates to a pharmaceutical composition comprising an Abeliophyllum distichum extract as an active ingredient for treating androgen receptor-related diseases. The Abeliophyllum distichum extract according to the present invention or isoquercetin has an inhibitory activity against the androgen receptor and an excellent therapeutic effect on benign prostatic hyperlasia animal models, thus this finding can apply widely to the industry for relevant therapeutic agents for androgen receptor-related diseases such as benign prostatic hyperplasia, androgen-dependent hair loss, dysuria, and prostate cancer.
-
-
-
-
-
-
-
-
-